INDOCOLLYRE O.1 % EYE DROPS Israel - English - Ministry of Health

indocollyre o.1 % eye drops

salomon,levin & elstein ltd - indomethacin - drops - indomethacin 0.1 % - indometacin - indometacin - inhibition of myosis during surgery. prevention of inflammation subsequent to cataract surgery or surgery of the anterior chamber of the eye. treatment of ocular pain following photorefractive keratectomy for the first few days after surgery.

Montelukast 10mg film-coated tablets United Kingdom - English - myHealthbox

montelukast 10mg film-coated tablets

warren generics s.r.o - montelukast sodium - film-coated tablets - 10mg - drugs for obstructive airway diseases, leukotriene receptor antagonists - it is indicated in the treatment of asthma as addon therapy in adolescent of 15 years of age and older and adults with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom “as-needed” short acting β-agonists provide inadequate clinical control of asthma. in those asthmatic patients in whom montelukast is indicated in asthma, it can also provide symptomatic relief of seasonal allergic rhinitis.

Indoco Metformin New Zealand - English - Medsafe (Medicines Safety Authority)

indoco metformin

miro healthcare limited - metformin hydrochloride 500mg - film coated tablet - 500 mg - active: metformin hydrochloride 500mg excipient: colloidal silicon dioxide hypromellose e-15 macrogol 6000 magnesium stearate maize starch povidone propylene glycol purified talc purified water   sodium starch glycolate titanium dioxide - to control hyperglycaemia in metformin responsive, stable, mild, non-ketosis prone, maturity onset type of diabetes (type ii) which cannot be controlled by proper dietary management, exercise and weight reduction or when insulin therapy is not appropriate. it may be used alone or in combination with sulphonylurea therapy. metformin can be of value for the treatment of obese diabetics. it may also be used as adjuvant therapy in insulin-dependent diabetics especially if they are overweight.

Indoco Metformin New Zealand - English - Medsafe (Medicines Safety Authority)

indoco metformin

miro healthcare limited - metformin hydrochloride 850mg - film coated tablet - 850 mg - active: metformin hydrochloride 850mg excipient: colloidal silicon dioxide hypromellose e-15 macrogol 6000 magnesium stearate maize starch povidone propylene glycol purified talc purified water   sodium starch glycolate titanium dioxide - to control hyperglycaemia in metformin responsive, stable, mild, non-ketosis prone, maturity onset type of diabetes (type ii) which cannot be controlled by proper dietary management, exercise and weight reduction or when insulin therapy is not appropriate. it may be used alone or in combination with sulphonylurea therapy. metformin can be of value for the treatment of obese diabetics. it may also be used as adjuvant therapy in insulin-dependent diabetics especially if they are overweight.

OLANZAPINE tablet United States - English - NLM (National Library of Medicine)

olanzapine tablet

indoco remedies limited - olanzapine (unii: n7u69t4szr) (olanzapine - unii:n7u69t4szr) - oral olanzapine tablets are indicated for the treatment of schizophrenia. efficacy was established in three clinical trials in adult patients with schizophrenia: two 6-week trials and one maintenance trial. in adolescent patients with schizophrenia (ages 13-17), efficacy was established in one 6-week trial [see clinical studies (14.1)]. when deciding among the alternative treatments available for adolescents, clinicians should consider the increased potential (in adolescents as compared with adults) for weight gain and dyslipidemia. clinicians should consider the potential long-term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents [see warnings and precautions (5.5)]. monotherapy — oral olanzapine tablets are indicated for the acute treatment of manic or mixed episodes associated with bipolar i disorder and maintenance treatment of bipolar i disorder. efficacy was established in three clinical trials in adult patients